Cory Peterson

TL;DR: Genome-wide data and high-resolution array profiling demonstrated that there is no common specific subkaryotypic alteration that is required for reprograming and that reprogramming does not lead to genomic instability, and suggest that iPSCs should be considered a unique subtype of pluripotent cell.

TL;DR: Treatment with an ERα ligand is highly selective in vivo, mediating both anti-inflammatory and neuroprotective effects in EAE, and is capable of recapitulating the estrogen-mediated protection in clinical EAE.

TL;DR: Novel small molecules that improve survival by inhibiting either Rho‐kinase or protein kinase C are identified by identifying groups of pathway targets that are important for modifying survival.

TL;DR: A novel approach for the efficient, consistent expansion of human ESCs and iPSCs using laser sectioning, instead of mechanical devices or enzymes, to divide cultures into defined size clumps for propagation, maintained the pluripotency, quality, and genetic stability of ESCs/iPSCs and led to enhanced differentiation potential.